Emerald Achieves Top Performer Status in Clean Technology & Life Science Sector for 2nd Consecutive Year
Emerald Health Therapeutics, Inc. (TSX-V:EMH)
(OTCQX:EMHTF) ("Emerald") has achieved the #1 ranking in the 2018 TSX
Venture 50™ for the clean technology & life science sector and is
recognized as a top performing company for the second consecutive year.
The TSX Venture 50™ is the TSX Venture Exchange’s annual ranking of
Canada’s top 50 emerging publicly traded companies.
“Emerald,
like all the companies in the TSX Venture 50™ and in the rapidly
growing cannabis sector, aspires to build a growing and differentiated
business that will provide notable value to shareholders. In achieving
#1 status in our sector in 2018, I extend a big thank you to our entire
team for their effort and our shareholders for their support,” said
Chris Wagner, CEO of Emerald. “We are executing very well on our major
production expansion projects, are well-financed, and are advancing
unique product innovation and marketing initiatives. We believe these
factors strongly position Emerald for the anticipated legal adult-use
cannabis market in Canada and for emerging international opportunities.”
Winner selections are based on a formula with
equal weighting given to share price appreciation, market capitalization
growth, and trading volume for the year ending December 31, 2017. The
TSX Venture 50™ acknowledges the top 10 performing companies listed on
the TSX Venture Exchange in five industry sectors: mining, oil &
gas, clean technology & life sciences, diversified industries, and
technology.
The TSXV created a video profile on Emerald and other 2018 TSX Venture 50™ winners, available at www.tsx.com/venture50.
Earlier
this month Emerald announced that it had been upgraded to Tier 1 on the
the TSX Venture Exchange. This status was based on standards regarding
historical financial performance, stage of development, and financial
resources. Tier 1 is the highest tier of the TSX-V and is reserved for
more advanced issuers with greater financial resources.
Emerald Health Therapeutics, Inc. (TSX-V:EMH) (OTCQX:EMHTF) operates through Emerald Health Botanicals Inc. ("Botanicals"), a wholly owned subsidiary and Licensed Producer under Canada’s Access to Cannabis for Medical Purposes Regulations. Through Botanicals, Emerald is authorized to produce and sell dried medical cannabis flower and medical cannabis oil. It currently operates an indoor facility in Victoria, BC, and is building a 500,000 s.f. greenhouse on 32 acres in Metro Vancouver, with expansion potential to 1 million s.f. to serve the anticipated legal Canadian adult-use cannabis market starting in 2018. Emerald also owns 50% of Pure Sunfarms Inc., a partnership with Village Farms International Inc. that is converting an existing 1.1 million s.f. greenhouse in Delta, BC from growing tomatoes to growing cannabis. Emerald’s team is highly experienced in life sciences, product development and large-scale agribusiness. Emerald is part of the Emerald Health group, which is broadly focused on developing pharmaceutical, botanical and nutraceutical products that may provide wellness and medical benefits by interacting with the human body’s endocannabinoid system.
No comments:
Post a Comment